Skip to content
Menu

Head-to-head comparison

Ivy Rx vs Nova MD

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Ranked #106Desk pick
Ivy Rx

Telehealth provider offering tiered compounded semaglutide and tirzepatide programs.

From $175/mo (lowest dose rung) sema · From $275/mo (lowest dose rung) tirz · Verified July 2026

Marked down on: Limited public information on program details

vs
Ranked #248
Nova MD

Nova MD is a telehealth platform offering compounded semaglutide and tirzepatide on 1-month and 3-month plans, with an uncommon explicit microdose program for both molecules.

$175/mo sema · $225/mo tirz · Verified July 2026

Marked down on: Legal entity name and state of incorporation not disclosed

FDAWarning letter issued to Try Nova in September 2025. See the FDA warning-letter database.

Ivy Rx takes this head-to-head with the higher Desk Score, 77/100 (C+) against 65/100 (C) for Nova MD. Nova MD still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Ivy Rx

77/100

C+

Overall

Nova MD

65/100

C

Price transparency

78
86

State access

86
24

Molecule range

72
72

Onboarding speed

74
77

Support responsiveness

78
81

Licensing & trust

73
46

The spec sheet

FieldIvy RxNova MD
SemaglutideFrom $175/molowest dose rung$175/mo (starting dose, compounded)$175/mo$175/mo (compounded)
TirzepatideFrom $275/molowest dose rung$275/mo (starting dose, compounded)$225/mo$225/mo (compounded)
CoverageAll 50 statesNot listed on Nova MD's site (checked July 2026)
Brand-nameCompounded onlyCompounded only
Oral optionInjectable onlyInjectable only
Best forMainstream telehealth GLP-1 access.Lowest 3-month compounded pricing with an explicit microdose program.
Desk Score77/100C+65/100C

The verdict

Desk pick — Ivy Rx

Ivy Rx takes this head-to-head with the higher Desk Score, 77/100 (C+) against 65/100 (C) for Nova MD. Nova MD still holds its ground where its strengths line up with yours.

Choose Ivy Rx if…

Mainstream telehealth GLP-1 access.

From $175/mo (lowest dose rung) sema · From $275/mo (lowest dose rung) tirz · All 50 states

Choose Nova MD if…

Lowest 3-month compounded pricing with an explicit microdose program.

$175/mo sema · $225/mo tirz

FDAWarning letter issued to Try Nova in September 2025. See the FDA warning-letter database.

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Ivy Rx · Nova MD.

Also here

CoreAge Rx leads the whole ranking at 94/100

Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.